Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis

被引:22
作者
Kanters, SDJM
Banga, JD
Stolk, RP
Algra, A
机构
[1] Univ Utrecht Hosp, Dept Internal Med, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht Hosp, Julius Ctr Patient Oriented Res, NL-3508 GA Utrecht, Netherlands
关键词
cardiovascular disease; determinants; diabetes; incidence; mortality;
D O I
10.1191/135886399673396635
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
Patients with diabetes mellitus are at increased risk of developing atherosclerotic disease. The extent of this additional risk and its determinants are not well known, but this information is needed for sample-size estimations in intervention studies. Therefore, a meta-analysis of epidemiologic studies on this subject was performed. Medline was searched from 1966 onwards, including the reference lists of all relevant publications, A total of 27 prospective follow-up studies in the English language that allowed calculation of the unadjusted incidence of one of the predefined outcome events were included. The influence of age, sex, type of diabetes, duration of diabetes, year of study, HbA(1c), cholesterol level, blood pressure and smoking on these incidences was studied by means of univariate Poisson regression analysis. Overall total mortality was 2.9% per year (95% CI 2.8-3.0; 27 studies), and for death from all vascular causes was 1.4% per year (95% CI 1.3-1.4; 16 studies). Only two studies were found that reported on the incidence of the composite outcome 'event death from all vascular causes, non-fatal myocardial infarction, or non-fatal stroke'. In univariate analysis, age, year of study, total cholesterol and systolic blood pressure were positively related to total mortality and death from all vascular causes. After adjustment for age, or limiting the analyses to studies in patients with type 2 diabetes only (n = 11), these relationships remained statistically significant. In conclusion, the overall yearly total mortality in diabetes mellitus is 2.9% and for death from all vascular causes is 1.4%. There are few data on the incidence of composite cardiovascular outcome events.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 51 条
[1]
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]
LONG-TERM GLYCEMIC CONTROL RELATES TO MORTALITY IN TYPE-II DIABETES [J].
ANDERSSON, DKG ;
SVARDSUDD, K .
DIABETES CARE, 1995, 18 (12) :1534-1543
[3]
Microalbuminuria cannot predict cardiovascular death in Japanese subjects with non-insulin-dependent diabetes mellitus [J].
Araki, S ;
Kikkawa, R ;
Haneda, M ;
Koya, D ;
Togawa, M ;
Liang, PM ;
Shigeta, Y .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1995, 9 (04) :323-325
[4]
EFFECT OF PICOTAMIDE ON THE CLINICAL PROGRESSION OF PERIPHERAL VASCULAR-DISEASE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY [J].
BALSANO, F ;
VIOLI, F .
CIRCULATION, 1993, 87 (05) :1563-1569
[5]
SEX DIFFERENTIAL IN ISCHEMIC-HEART-DISEASE MORTALITY IN DIABETICS - A PROSPECTIVE POPULATION-BASED STUDY [J].
BARRETTCONNOR, E ;
WINGARD, DL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 118 (04) :489-496
[6]
THE EFFECT OF PROTEINURIA ON RELATIVE MORTALITY IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
ANDERSEN, PK ;
DECKERT, T .
DIABETOLOGIA, 1985, 28 (08) :590-596
[7]
BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[8]
DAMSGAARD EM, 1992, KIDNEY INT, V41, P731
[9]
DEGRAUW WJC, 1995, DIABETIC MED, V12, P117
[10]
DIABETES-MELLITUS AND MACROVASCULAR COMPLICATIONS - AN EPIDEMIOLOGIC PERSPECTIVE [J].
DONAHUE, RP ;
ORCHARD, TJ .
DIABETES CARE, 1992, 15 (09) :1141-1155